Company Selected - Takeda Pharmaceutical Co. Ltd. - Valuation
| Fiscal Year is From April To March | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | View Chart |
|---|---|---|---|---|---|
| EV \ EBITDA Ratio | 9.37x | 9.06x | 9.63x | 8.88x | |
| EV \ Sales Ratio | 2.41x | 2.43x | 2.42x | 2.33x | |
| P \ E Ratio | 202.47x | 48.51x | 64.60x | 30.32x | |
| Forward P \ E Ratio | - | - | - | - | |
| P \ CF Ratio | 5.95x | 6.60x | 7.24x | 6.05x | |
| P \ S Ratio | 1.52x | 1.48x | 1.52x | 1.38x | |
| P \ BV Ratio | 0.939x | 0.9674x | 1.01x | 0.8503x | |
| P \ Tangible BV Ratio (Excluding Intagible Assets (Including Goodwill)) | 1.75x | 1.93x | 2.11x | 1.82x |